![](https://investorshub.advfn.com/uicon/112058.png?cb=1503418608)
Wednesday, March 10, 2010 11:53:35 AM
Date : 03/10/2010 @ 8:00AM
Source : PR Newswire
Stock : American Oriental Bioengineering (AOB)
Quote : 4.58 0.09 (2.00%) @ 11:51AM
American Oriental Bioengineering to Report Fourth Quarter and Full Year 2009 Financial Results on March 15, 2010
NEW YORK, March 10 /PRNewswire-Asia-FirstCall/ --
American Oriental Bioengineering, Inc. , ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that it plans to release fourth quarter and full year 2009 financial results on Monday, March 15, 2010, before the market opens.
The Company will hold a conference call at 8:00 am ET on Monday, March 15, to discuss its results. Listeners may access the call by dialing 1-800-261-3417 or 1-617-614-3673 for international callers, access code: 25821500. A webcast will also be available through AOB's website at http://www.bioaobo.com/ .
A replay of the call will be available through March 22, 2010. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 59269795.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.
Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, including the Form 10-K for the year ended December 31, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.
For more information, please contact:
Integrated Corporate Relations, Inc.
Ashley M. Ammon
Tel: +1-646-277-1200
DATASOURCE: American Oriental Bioengineering, Inc.
CONTACT: Ashley M. Ammon, +1-646-277-1200, of Integrated CorporateRelations, Inc.
Web site: http://www.bioaobo.com/
Longterm Investment, Biotechs & High Yield Dividend Stocks ... #board-11828
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM